# M&T Bank Corp: financial statements, quarterly

MTB · NYSE · CIK 36270 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mtb.md) · [Financials](/companies/mtb/financials.md) · [Filings](/companies/mtb/filings.md) · [Insiders](/companies/mtb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mtb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [360](/filings/0001628280-24-045198.md) | [365 d](/filings/0000036270-26-000010.md) | [367](/filings/0001628280-25-022036.md) | [388](/filings/0000036270-25-000011.md) | [394](/filings/0000036270-25-000024.md) | [392 d](/filings/0000036270-26-000010.md) | [397](/filings/0000036270-26-000034.md) | [417](/filings/0000036270-26-000050.md) | [423](/filings/0000036270-25-000024.md) | [420 d](/filings/0000036270-26-000010.md) | [418](/filings/0000036270-26-000034.md) | [442](/filings/0000036270-26-000050.md) |
| Interest expense | $m | [866](/filings/0000950170-23-059364.md) | [1,018 d](/filings/0000950170-24-017990.md) | [1,065](/filings/0000950170-24-052773.md) | [1,071](/filings/0001628280-24-034695.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [217](/filings/0001628280-24-045198.md) | [144 d](/filings/0000036270-26-000010.md) | [133](/filings/0001628280-25-022036.md) | [200](/filings/0000036270-25-000011.md) | [188](/filings/0000036270-25-000024.md) | [201 d](/filings/0000036270-26-000010.md) | [177](/filings/0000036270-26-000034.md) | [219](/filings/0000036270-26-000050.md) | [233](/filings/0000036270-25-000024.md) | [212 d](/filings/0000036270-26-000010.md) | [199](/filings/0000036270-26-000034.md) | [245](/filings/0000036270-26-000050.md) |
| Net income | $m | [690](/filings/0001628280-24-045198.md) | [482 d](/filings/0000036270-26-000010.md) | [531](/filings/0001628280-25-022036.md) | [655](/filings/0000036270-25-000011.md) | [721](/filings/0000036270-25-000024.md) | [681 d](/filings/0000036270-26-000010.md) | [584](/filings/0000036270-26-000034.md) | [716](/filings/0000036270-26-000050.md) | [792](/filings/0000036270-25-000024.md) | [759 d](/filings/0000036270-26-000010.md) | [664](/filings/0000036270-26-000034.md) | [818](/filings/0000036270-26-000050.md) |
| Diluted EPS | $ per share | [3.98](/filings/0001628280-24-045198.md) | not reported | [3.02](/filings/0001628280-25-022036.md) | [3.73](/filings/0000036270-25-000011.md) | [4.02](/filings/0000036270-25-000024.md) | not reported | [3.32](/filings/0000036270-26-000034.md) | [4.24](/filings/0000036270-26-000050.md) | [4.82](/filings/0000036270-25-000024.md) | not reported | [4.13](/filings/0000036270-26-000034.md) | [5.32](/filings/0000036270-26-000050.md) |
| Basic EPS | $ per share | [4.00](/filings/0001628280-24-045198.md) | not reported | [3.04](/filings/0001628280-25-022036.md) | [3.75](/filings/0000036270-25-000011.md) | [4.04](/filings/0000036270-25-000024.md) | not reported | [3.33](/filings/0000036270-26-000034.md) | [4.26](/filings/0000036270-26-000050.md) | [4.85](/filings/0000036270-25-000024.md) | not reported | [4.16](/filings/0000036270-26-000034.md) | [5.35](/filings/0000036270-26-000050.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [209](/filings/0000950170-23-059364.md) | [208](/filings/0001628280-25-006267.md) | [215](/filings/0000950170-24-052773.md) | [209](/filings/0001628280-24-034695.md) | [212](/filings/0001628280-24-045198.md) | [208](/filings/0000036270-26-000010.md) | [210](/filings/0001628280-25-022036.md) | [212](/filings/0000036270-25-000011.md) | [211](/filings/0000036270-25-000024.md) | [214](/filings/0000036270-26-000050.md) | [215](/filings/0000036270-26-000034.md) | [219](/filings/0000036270-26-000050.md) |
| Total liabilities | $bn | [183](/filings/0000950170-23-059364.md) | [181](/filings/0001628280-25-006267.md) | [188](/filings/0000950170-24-052773.md) | [180](/filings/0001628280-24-034695.md) | [183](/filings/0001628280-24-045198.md) | [179](/filings/0000036270-26-000010.md) | [181](/filings/0001628280-25-022036.md) | [183](/filings/0000036270-25-000011.md) | [183](/filings/0000036270-25-000024.md) | [184](/filings/0000036270-26-000050.md) | [187](/filings/0000036270-26-000034.md) | [191](/filings/0000036270-26-000050.md) |
| Long-term debt | $bn | [7.1](/filings/0000950170-23-059364.md) | [8.2](/filings/0001628280-25-006267.md) | [11.5](/filings/0000950170-24-052773.md) | [11.3](/filings/0001628280-24-034695.md) | [11.6](/filings/0001628280-24-045198.md) | [12.6](/filings/0000036270-26-000010.md) | [10.5](/filings/0001628280-25-022036.md) | [12.4](/filings/0000036270-25-000011.md) | [12.9](/filings/0000036270-25-000024.md) | [10.9](/filings/0000036270-26-000050.md) | [11.2](/filings/0000036270-26-000034.md) | [13.6](/filings/0000036270-26-000050.md) |
| Short-term borrowings | $bn | [6.7](/filings/0000950170-23-059364.md) | [5.3](/filings/0001628280-25-006267.md) | [4.8](/filings/0000950170-24-052773.md) | [4.8](/filings/0001628280-24-034695.md) | [2.6](/filings/0001628280-24-045198.md) | [1.1](/filings/0000036270-26-000010.md) | [1.6](/filings/0001628280-25-022036.md) | [2.1](/filings/0000036270-25-000011.md) | [2.1](/filings/0000036270-25-000024.md) | [2.1](/filings/0000036270-26-000050.md) | [7.9](/filings/0000036270-26-000034.md) | [4.6](/filings/0000036270-26-000050.md) |
| Shareholders' equity | $bn | [26.2](/filings/0001628280-24-045198.md) | [27.0](/filings/0000036270-26-000010.md) | [27.2](/filings/0000036270-25-000011.md) | [28.4](/filings/0000036270-25-000024.md) | [28.9](/filings/0000036270-25-000024.md) | [29.0](/filings/0000036270-26-000050.md) | [29.0](/filings/0000036270-26-000050.md) | [28.5](/filings/0000036270-26-000050.md) | [28.7](/filings/0000036270-25-000024.md) | [29.2](/filings/0000036270-26-000050.md) | [28.0](/filings/0000036270-26-000050.md) | [27.9](/filings/0000036270-26-000050.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,420 d](/filings/0001628280-24-045198.md) | [800 d](/filings/0000036270-26-000010.md) | [608](/filings/0001628280-25-022036.md) | [1,354 d](/filings/0000036270-25-000011.md) | [(28.0) d](/filings/0000036270-25-000024.md) | [1,676 d](/filings/0000036270-26-000010.md) | [635](/filings/0000036270-26-000034.md) | [844 d](/filings/0000036270-26-000050.md) | [1,001 d](/filings/0000036270-25-000024.md) | [523 d](/filings/0000036270-26-000010.md) | [1,012](/filings/0000036270-26-000034.md) | [1,268 d](/filings/0000036270-26-000050.md) |
| Dividends paid | $m | [216 d](/filings/0001628280-24-045198.md) | [216 d](/filings/0000036270-26-000010.md) | [221](/filings/0001628280-25-022036.md) | [225 d](/filings/0000036270-25-000011.md) | [225 d](/filings/0000036270-25-000024.md) | [224 d](/filings/0000036270-26-000010.md) | [225](/filings/0000036270-26-000034.md) | [213 d](/filings/0000036270-26-000050.md) | [233 d](/filings/0000036270-25-000024.md) | [228 d](/filings/0000036270-26-000010.md) | [227](/filings/0000036270-26-000034.md) | [218 d](/filings/0000036270-26-000050.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-24-045198.md) | [0.0 d](/filings/0000036270-26-000010.md) | [0.0](/filings/0001628280-25-022036.md) | [0.0 d](/filings/0000036270-25-000011.md) | [198 d](/filings/0000036270-25-000024.md) | [198 d](/filings/0000036270-26-000010.md) | [656](/filings/0000036270-26-000034.md) | [1,069 d](/filings/0000036270-26-000050.md) | [404 d](/filings/0000036270-25-000024.md) | [502 d](/filings/0000036270-26-000010.md) | [1,238](/filings/0000036270-26-000034.md) | [460 d](/filings/0000036270-26-000050.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [176](/filings/0000950170-23-059364.md) | [168](/filings/0000950170-24-052773.md) | [166](/filings/0001628280-24-034695.md) | [167](/filings/0001628280-24-045198.md) | [167](/filings/0001628280-25-022036.md) | [168](/filings/0000036270-25-000011.md) | [168](/filings/0000036270-25-000024.md) | [165](/filings/0000036270-26-000034.md) | [160](/filings/0000036270-26-000050.md) | [157](/filings/0000036270-25-000024.md) | [150](/filings/0000036270-26-000034.md) | [147](/filings/0000036270-26-000050.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 144,416,262 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0000036270-26-000050.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.